SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/42422"
 

Search: onr:"swepub:oai:gup.ub.gu.se/42422" > Clinical trial desi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Clinical trial design--towards better practices

Correia, O. (author)
Faergemann, Jan, 1948 (author)
Gothenburg University,Göteborgs universitet,Institutionen för särskilda specialiteter, Avdelningen för dermatologi och venereologi,Institute of Selected Clinical Sciences, Department of Dermatology and Venereology
Nowicki, R. (author)
show more...
Ro, B. I. (author)
show less...
 (creator_code:org_t)
2005
2005
English.
In: J Eur Acad Dermatol Venereol. ; 19 Suppl 1, s. 40-2
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVES: To review methodological approaches used in recent publications in onychomycosis clinical research. To identify key methodological criteria to ensure conclusive and reliable clinical results. METHODS: A Medline search for recent articles on onychomycosis treatment revealed considerable variation in inclusion criteria, definitions and methodology, rendering comparisons difficult. RESULTS: Careful diagnosis at trial entry is critical and predisposing factors affecting overall results are rarely considered at enrolment. Clear definitions are required, notably for the terms mycological, clinical and total cure. A consensus was reached that only studies that are evidence-based, controlled and double-blind with less than 10-15% of patients lost to follow-up should be accepted. Results should be interpreted with caution if a given treatment is found to be less effective than previously reported, even if the results are published in a recognized journal. It was agreed that an explanatory/pilot study should be done initially to determine whether there is a reason to believe that a new therapy is effective. If promising results are obtained, a double-blind, randomized study comparing the new therapy with either an existing therapy (preferably) or a placebo may be initiated. CONCLUSIONS: Sample size, and inclusion and exclusion criteria should be clearly determined. Efficacy criteria should include mycological, clinical and total cure rates. Finally, studies of toenail and fingernail onychomycosis must last at least 18 and 9 months, respectively.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)

Keyword

Administration
Oral
Administration
Topical
Antibiotics
Antifungal/therapeutic use
Antifungal Agents/*therapeutic use
Dose-Response Relationship
Drug
Double-Blind Method
Drug Administration Schedule
Evidence-Based Medicine
Female
Humans
Male
Onychomycosis/diagnosis/*drug therapy
Prognosis
Randomized Controlled Trials/*methods/*standards
Research Design/standards
Treatment Outcome

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Correia, O.
Faergemann, Jan, ...
Nowicki, R.
Ro, B. I.
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Dermatology and ...
Articles in the publication
By the university
University of Gothenburg

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view